Your success begins and ends with the caliber of your people and their commitment to the organization. We align leadership, talent and culture to support emerging global workforce needs and improve business performance.
Talent management is vital to business performance. A&M develops and implements strategies to close leadership/technical talent gaps, drive a high performance culture and improve retention and engagement of employees.
Our professionals have the experience and expertise to provide wide-ranging support across your human resource functions, aligning your human resource department with your overall company strategy through:
Not all organizations have the ability to have a full time CHRO, and some may be dealing in a transition period awaiting a new incumbent.
We understand that a change in leadership, whether through retirement, a change in control or another transaction, can hold some of the highest risk to shareholders.
Creating a clear strategy for how your employees support your business goals is a necessity an organization’s success.
With globalizing markets, rapid advancements in technology and the evolving regulatory environment surrounding human capital, the Human Resources function of most organizations continue to face challenges with respect to their overall strategy.
People are a company’s most valuable resource. When one or more members of a team leaves, organizations can be hard-pressed for resources.
We can review and/or redesign your existing welfare benefit plans with an emphasis towards maximizing cost efficiency, while complying with statutes, plan provisions, and the various requirements of the Department of Labor, the Internal Revenue Service, and other government agencies.
The Roses Have Wilted and Only a Few Less Thorns—Australia’s Finalised Third Party Debt Test Guidance
October 30, 2025
Explore the restrictive interpretation of third party debt in Australia's PCG 2025/2, with minimal concessions and a hardline approach by the Commissioner.
EU VAT Quarterly Wrap-up –– Q3 2025
October 28, 2025
In this Q3 2025 edition of our VAT Quarterly Wrap-up, we address three VAT topics which kept the CJEU busy in the third quarter of 2025. Alongside these cases, we selected a number of developments relevant for companies active in EU Member States.
A Transfer Pricing Prescription for Thai Pharma Distributors
October 22, 2025
Explore transfer pricing challenges in the pharmaceutical sector, shaped by high profitability, R&D investments, patent protections, and marketing intangibles.
Strict Criteria for Domestic Exemption of EIFEL Rules' Excluded Entity Exception
October 22, 2025
CRA states that holding foreign, personal use property may prevent taxpayers from relying on “domestic exemption” from EIFEL.
